Proprietary AI analyst is now available
- Public Comps
- Stepan
Stepan Valuation Multiples
Discover Stepan's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Elkem, Tronox Holdings, Boubyan Petrochemical, Elementis and more.
Stepan Overview
About Stepan
Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.
Founded
1959
HQ

Employees
2.4K
Website
Sectors
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialStepan Financials
Stepan reported last 12-month revenue of $2B and EBITDA of $213M.
In the same LTM period, Stepan generated $284M in gross profit, $213M in EBITDA, and $35M in net income.
Revenue (LTM)
Stepan P&L
In the most recent fiscal year, Stepan reported revenue of $2B and EBITDA of $212M.
Stepan is profitable as of last fiscal year, with gross margin of 12%, EBITDA margin of 9%, and net margin of 2%.
Financial data powered by Morningstar, Inc.
Stepan Stock Performance
Stepan has current market cap of $1B, and enterprise value of $2B.
Market Cap Evolution
Stepan's stock price is $54.18.
Stepan share price increased by 2.5% in the last 30 days, and decreased by 0.7% in the last year.
Stepan has an EPS (earnings per share) of $2.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $1B | -0.5% | 2.5% | 8.4% | -0.7% | $2.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialStepan Valuation Multiples
Stepan trades at 0.7x EV/Revenue multiple, and 8.4x EV/EBITDA.
EV / Revenue (LTM)
Stepan Financial Valuation Multiples
As of June 17, 2026, Stepan has market cap of $1B and EV of $2B.
Stepan has a P/E ratio of 35.2x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Stepan Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Stepan Margins & Growth Rates
Stepan grew revenue by 8% and EBITDA by 8% in the last fiscal year.
In the most recent fiscal year, Stepan reported gross margin of 12%, EBITDA margin of 9%, and net margin of 2%.
Stepan Margins
Stepan Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Stepan Operational KPIs
Stepan's revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $0.1M for the same period.
Stepan's Rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Stepan's Rule of X is 28% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Stepan Competitors
Stepan competitors include Elkem, Tronox Holdings, Boubyan Petrochemical, Elementis, Chemtrade Logistics, CVR Partners, Shanghai C&D Innostic, Unipar, Braskem and Redox.
Most Stepan public comparables operate across Chemicals.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.7x | 0.9x | 5.5x | 8.3x | |||
| 1.6x | 1.5x | 13.5x | 13.3x | |||
| 5.5x | - | 10.0x | - | |||
| 2.3x | 2.3x | 9.3x | 9.1x | |||
| 1.5x | - | 6.8x | - | |||
| 2.7x | 2.7x | 7.7x | - | |||
| 0.6x | - | 16.0x | - | |||
| 1.8x | 1.8x | 6.8x | 7.9x | |||
This data is available for Pro users. Sign up to see all Stepan competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Stepan
Stepan has acquired 2 companies to date.
Last acquisition by Stepan was on September 26th 2022. Stepan acquired PerformanX Specialty Chemicals for undisclosed valuation.
Latest Acquisitions by Stepan
| Description | PerformanX Specialty Chemicals manufactures anionic and nonionic surfactants, emulsifiers, and wetting agents for personal care, industrial cleaning, and agriculture applications. The Texas-based producer offers custom formulations with biodegradability profiles meeting EPA standards. Product lines include sulfate-free alternatives and high-foam concentrates for household detergents. | Clariant AG is a Switzerland-based specialty chemicals company with world-wide operations. The company reports in three business areas: care chemicals, absorbents and additives and catalysts. Care chemicals mainly targets consumer end markets such as personal care and homecare, but it also has an industrial component. Absorbents and additives encompass Clariant’s coatings and adhesives, absorbents, and plastics segments. Catalysts manufacturers process catalysts, mainly for petrochemical and syngas plants. |
| HQ Country | ||
| HQ City | Columbus, OH | San Jose, CA |
| Deal Date | 26 Sep 2022 | 17 Sep 2020 |
| Valuation | undisclosed | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Stepan acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Stepan
| When was Stepan founded? | Stepan was founded in 1959. |
| Where is Stepan headquartered? | Stepan is headquartered in United States. |
| How many employees does Stepan have? | As of today, Stepan has over 2K employees. |
| Who is the CEO of Stepan? | Stepan's CEO is Luis E. Rojo. |
| Is Stepan publicly listed? | Yes, Stepan is a public company listed on NYSE. |
| What is the stock symbol of Stepan? | Stepan trades under SCL ticker. |
| When did Stepan go public? | Stepan went public in 1972. |
| Who are competitors of Stepan? | Stepan main competitors include Elkem, Tronox Holdings, Boubyan Petrochemical, Elementis, Chemtrade Logistics, CVR Partners, Shanghai C&D Innostic, Unipar, Braskem, Redox. |
| What is the current market cap of Stepan? | Stepan's current market cap is $1B. |
| What is the current revenue of Stepan? | Stepan's last 12 months revenue is $2B. |
| What is the current revenue growth of Stepan? | Stepan revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Stepan? | Current revenue multiple of Stepan is 0.7x. |
| What is the current EBITDA of Stepan? | Stepan's last 12 months EBITDA is $213M. |
| What is Stepan's EBITDA margin? | Stepan's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of Stepan? | Current EBITDA multiple of Stepan is 8.4x. |
| How many companies Stepan has acquired to date? | As of June 2026, Stepan has acquired 2 companies. |
| What was the largest acquisition by Stepan? | None of the M&A deals Stepan has completed have disclosed valuations. |
| What companies Stepan acquired? | Stepan acquired Clariant and PerformanX Specialty Chemicals. |
| In how many companies Stepan has invested to date? | Stepan hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Stepan
Lists including Stepan
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

